Trial Type: Lymphoma

A Phase Ib/II, open-label, multicenter study with a non-randomized stage evaluating the safety, pharmacokinetics, and efficacy of Mosunetuzumab plus Lenalidomide ( + LEN), and a randomized stage evaluating the safety, tolerability, and pharmacokinetics of SC versus IV Mosunetuzumab + LEN in patients with follicular lymphoma

ALTE2131: Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer

BH-P-GOLSEEK-4: A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma

LS-P-MACE: A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination with Other Anticancer Agents in Participants with Mature B-Cell Malignancies

S2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma

A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older patients with Mantle Cell Lymphoma

LS-P-LOTIS-7: A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

SWOGS2205: ICE COMPRESS: Randomized Trial of Limb Cryocompression Versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy

AHOD2131: A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

LS-P-POM: A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects with Mature B-Cell Malignancies